Table 1 Patient characteristics
All patients (n = 252) | Patients with pelvic sepsis (n = 27) | Patients without pelvic sepsis (n = 225) | P-value | |
|---|---|---|---|---|
Age (years) at surgery* | 75 (20–92) | 69 (50–85) | 76 (20–92) | 0.002 |
Male gender | 149 (59) | 18 (67) | 131 (58) | 0.53 |
BMI > 25 (kg/m2) | 130 (52) | 22 (82) | 108 (48) | 0.001 |
Medical history | ||||
Cardiovascular disease | 148 (59) | 15 (56) | 133 (59) | 0.68 |
Diabetes mellitus | 40 (16) | 7 (26) | 33 (15) | 0.27 |
Pulmonary disease | 27 (11) | 1 (4) | 26 (12) | 0.32 |
Immune suppression | 13 (5) | 0 | 13 (6) | 0.30 |
Smoking history | 0.80 | |||
Never | 142 (59) | 15 (56) | 127 (60) | |
Former | 67 (28) | 9 (33) | 58 (27) | |
Current | 31 (13) | 3 (11) | 28 (13) | |
ASA grade 3 or 4 | 107 (42) | 7 (26) | 100 (44) | 0.07 |
Albumin (g/L)* | 36 (11–48) | 37 (23–45) | 36 (11–48) | 0.47 |
CEA (µg/L)* | 4 (1–465) | 10 (1–72) | 4 (1–465) | 0.35 |
Creatinine (µmol/L)* | 78 (34–235) | 81 (47–143) | 78 (34–235) | 0.38 |
Tumour height* | 10 (5–15) | 10 (6–15) | 10 (5–15) | 0.38 |
Low 5 cm | 6 (2) | 0 | 6 (3) | |
Mid 6–10 cm | 131 (52) | 19 (70) | 112 (50) | |
High 11–15 cm | 115 (46) | 8 (30) | 107 (47) | |
TNM stage | 0.52 | |||
I | 35 (14) | 2 (7) | 33 (15) | |
II | 86 (34) | 12 (44) | 74 (33) | |
III | 90 (36) | 8 (30) | 82 (36) | |
IV | 39 (15) | 5 (19) | 34 (16) | |
Neoadjuvant radiotherapy | 128 (51) | 22 (81) | 106 (47)) | < 0.001 |
Short course/ surgery | 51 (20) | 12 (44) | 39 (17) | |
Short course/delayed surgery | 25 (10) | 1 (4) | 24 (11) | |
Long course without chemo | 6 (2) | 2 (7) | 4 (1) | |
Chemoradiotherapy | 46 (20) | 7 (26) | 39 (19) | 0.36 |
Neoadjuvant chemotherapy | 6 (2) | 1 (4) | 5 (2) | 0.47 |